Antibodies and obesity: a research study
Part of Hormones & metabolism clinical trials.
This study looks at whether certain antibodies in your blood are linked to obesity. By participating, you may help researchers understand why some people struggle with weight, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in the Region of Southern Denmark.
- Your BMI (body mass index) must be above 30.
- You must be between 18 and 60 years old.
- You cannot have taken GLP-1 medications (such as Ozempic or Wegovy) before.
- You cannot have had weight-loss surgery.
- You cannot have type 1 diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation affects heart disease and diabetes. It may help find new ways to prevent or treat these conditions.
This study looks at the range of diabetes and obesity in people aged 8 to 65 to better understand these conditions. If you join, researchers will evaluate your health to learn more about how diabetes and obesity affect people.
This study looks at how obesity and type 2 diabetes affect your body's ability to fight infections. By joining, you'll help researchers understand why some people with these conditions get more infections, which could lead to better prevention and treatment.
This is an observational study that follows generally healthy adults to understand how inflammation, diabetes (type 2), and weight/metabolic health relate to each other. It may help researchers figure out why different groups (including different ethnic backgrounds) have different health risks.
This study looks at how obesity and related conditions affect your body's ability to fight infections. It may help find ways to prevent illness in people with obesity.
This study looks at tiny particles released from fat tissue in people with and without obesity. It aims to understand differences that might help explain obesity-related health problems.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.